925 related articles for article (PubMed ID: 19929361)
1. Timing and duration of anti-alpha4beta1 integrin treatment after spinal cord injury: effect on therapeutic efficacy.
Fleming JC; Bao F; Chen Y; Hamilton EF; Gonzalez-Lara LE; Foster PJ; Weaver LC
J Neurosurg Spine; 2009 Nov; 11(5):575-87. PubMed ID: 19929361
[TBL] [Abstract][Full Text] [Related]
2. Alpha4beta1 integrin blockade after spinal cord injury decreases damage and improves neurological function.
Fleming JC; Bao F; Chen Y; Hamilton EF; Relton JK; Weaver LC
Exp Neurol; 2008 Dec; 214(2):147-59. PubMed ID: 19038604
[TBL] [Abstract][Full Text] [Related]
3. An integrin inhibiting molecule decreases oxidative damage and improves neurological function after spinal cord injury.
Bao F; Chen Y; Schneider KA; Weaver LC
Exp Neurol; 2008 Dec; 214(2):160-7. PubMed ID: 18926823
[TBL] [Abstract][Full Text] [Related]
4. Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment.
Weaver LC; Gris D; Saville LR; Oatway MA; Chen Y; Marsh DR; Hamilton EF; Dekaban GA
J Neurotrauma; 2005 Dec; 22(12):1375-87. PubMed ID: 16379576
[TBL] [Abstract][Full Text] [Related]
5. Transient blockade of the CD11d/CD18 integrin reduces secondary damage after spinal cord injury, improving sensory, autonomic, and motor function.
Gris D; Marsh DR; Oatway MA; Chen Y; Hamilton EF; Dekaban GA; Weaver LC
J Neurosci; 2004 Apr; 24(16):4043-51. PubMed ID: 15102919
[TBL] [Abstract][Full Text] [Related]
6. A therapeutic time window for anti-CD 11d monoclonal antibody treatment yielding reduced secondary tissue damage and enhanced behavioral recovery following severe spinal cord injury.
Ditor DS; Bao F; Chen Y; Dekaban GA; Weaver LC
J Neurosurg Spine; 2006 Oct; 5(4):343-52. PubMed ID: 17048772
[TBL] [Abstract][Full Text] [Related]
7. A monoclonal antibody to CD11d reduces the inflammatory infiltrate into the injured spinal cord: a potential neuroprotective treatment.
Saville LR; Pospisil CH; Mawhinney LA; Bao F; Simedrea FC; Peters AA; O'Connell PJ; Weaver LC; Dekaban GA
J Neuroimmunol; 2004 Nov; 156(1-2):42-57. PubMed ID: 15465595
[TBL] [Abstract][Full Text] [Related]
8. Effects of polyethylene glycol and magnesium sulfate administration on clinically relevant neurological outcomes after spinal cord injury in the rat.
Ditor DS; John SM; Roy J; Marx JC; Kittmer C; Weaver LC
J Neurosci Res; 2007 May; 85(7):1458-67. PubMed ID: 17410603
[TBL] [Abstract][Full Text] [Related]
9. Early anti-inflammatory treatment reduces lipid peroxidation and protein nitration after spinal cord injury in rats.
Bao F; Chen Y; Dekaban GA; Weaver LC
J Neurochem; 2004 Mar; 88(6):1335-44. PubMed ID: 15009633
[TBL] [Abstract][Full Text] [Related]
10. Effects of early surgical decompression on functional and histological outcomes after severe experimental thoracic spinal cord injury.
Jalan D; Saini N; Zaidi M; Pallottie A; Elkabes S; Heary RF
J Neurosurg Spine; 2017 Jan; 26(1):62-75. PubMed ID: 27636866
[TBL] [Abstract][Full Text] [Related]
11. Magnesium efficacy in a rat spinal cord injury model.
Wiseman DB; Dailey AT; Lundin D; Zhou J; Lipson A; Falicov A; Shaffrey CI
J Neurosurg Spine; 2009 Apr; 10(4):308-14. PubMed ID: 19441987
[TBL] [Abstract][Full Text] [Related]
12. Anti-alpha4beta1 integrin antibody induces receptor internalization and does not impair the function of circulating neutrophilic leukocytes.
Fleming JC; Bao F; Cepinskas G; Weaver LC
Inflamm Res; 2010 Aug; 59(8):647-57. PubMed ID: 20213330
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of the anti-CD11d treatment is reduced in rat models of spinal cord injury that produce significant levels of intraspinal hemorrhage.
Geremia NM; Hryciw T; Bao F; Streijger F; Okon E; Lee JHT; Weaver LC; Dekaban GA; Kwon BK; Brown A
Exp Neurol; 2017 Sep; 295():125-134. PubMed ID: 28587875
[TBL] [Abstract][Full Text] [Related]
14. A selective phosphodiesterase-4 inhibitor reduces leukocyte infiltration, oxidative processes, and tissue damage after spinal cord injury.
Bao F; Fleming JC; Golshani R; Pearse DD; Kasabov L; Brown A; Weaver LC
J Neurotrauma; 2011 Jun; 28(6):1035-49. PubMed ID: 21355819
[TBL] [Abstract][Full Text] [Related]
15. Thiazolidinedione class of peroxisome proliferator-activated receptor gamma agonists prevents neuronal damage, motor dysfunction, myelin loss, neuropathic pain, and inflammation after spinal cord injury in adult rats.
Park SW; Yi JH; Miranpuri G; Satriotomo I; Bowen K; Resnick DK; Vemuganti R
J Pharmacol Exp Ther; 2007 Mar; 320(3):1002-12. PubMed ID: 17167171
[TBL] [Abstract][Full Text] [Related]
16. The systemic inflammatory response after spinal cord injury in the rat is decreased by α4β1 integrin blockade.
Bao F; Omana V; Brown A; Weaver LC
J Neurotrauma; 2012 May; 29(8):1626-37. PubMed ID: 22150233
[TBL] [Abstract][Full Text] [Related]
17. Effect of 17beta-estradiol on functional outcome, release of cytokines, astrocyte reactivity and inflammatory spreading after spinal cord injury in male rats.
Ritz MF; Hausmann ON
Brain Res; 2008 Apr; 1203():177-88. PubMed ID: 18316064
[TBL] [Abstract][Full Text] [Related]
18. CD11d integrin blockade reduces the systemic inflammatory response syndrome after spinal cord injury.
Bao F; Brown A; Dekaban GA; Omana V; Weaver LC
Exp Neurol; 2011 Oct; 231(2):272-83. PubMed ID: 21784069
[TBL] [Abstract][Full Text] [Related]
19. (-)-Epigallocatechin-3-gallate (EGCG) modulates neurological function when intravenously infused in acute and, chronically injured spinal cord of adult rats.
Renno WM; Al-Khaledi G; Mousa A; Karam SM; Abul H; Asfar S
Neuropharmacology; 2014 Feb; 77():100-19. PubMed ID: 24071567
[TBL] [Abstract][Full Text] [Related]
20. Effect of combined treatment with melatonin and methylprednisolone on neurological recovery after experimental spinal cord injury.
Cayli SR; Kocak A; Yilmaz U; Tekiner A; Erbil M; Ozturk C; Batcioglu K; Yologlu S
Eur Spine J; 2004 Dec; 13(8):724-32. PubMed ID: 15232723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
